Cherry Hill, NJ, United States of America

Xiaochuan Shan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Trustees of the Univesity of Pennsylvania. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaochuan Shan. Retrieved from https://idiyas.com/inventor/xiaochuan-shan-9cp3witf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xiaochuan Shan: Inventor in Immunology

Introduction

Xiaochuan Shan is an inventor associated with Cherry Hill, New Jersey, and The Trustees of the University of Pennsylvania. His patent work concerns the modulation of regulatory T cells, which play a role in regulating immune responses.

Latest Patents

Shan is named on 1 patent: “Modulation of Regulatory T Cells by Human IL-18.” The invention describes compositions and methods for modulating the presence or activity of regulatory T cells in a subject.

Career Highlights

Shan’s listed patent reflects research focused on human IL-18 and its potential use in influencing regulatory T cells. The available information identifies The Trustees of the University of Pennsylvania as his affiliated organization.

Collaborations

His listed coworkers include Gwenn-ael Danet-Desnoyers and Carl H. June.

Conclusion

Xiaochuan Shan’s patent work connects human IL-18 research with methods for modulating regulatory T cells, in collaboration with colleagues associated with the University of Pennsylvania.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…